Skip to main content
. Author manuscript; available in PMC: 2010 Jul 27.
Published in final edited form as: Transplantation. 2009 Jul 27;88(2):180–187. doi: 10.1097/TP.0b013e3181ac11ea

Figure 4. Donor-specific delayed-type hypersensitivity (DTH) is decreased in α-MSHtreated hosts.

Figure 4

Ear swelling of naïve (negative control), subcutaneously primed (positive control) BALB/c hosts, sham-treated/untreated hosts and α-MSH-treated hosts were measured by a micrometer, 24 and 48 hours after ear challenge by donor cells at 3 weeks post corneal transplantation (n=5/group). α-MSH-treated hosts demonstrated a significantly suppressed degree of donor-specific ear swelling (DTH) as compared to control sham-treated hosts (*p = 0.008).